BIO-key International (NASDAQ:BKYI) Raised to “Hold” at Wall Street Zen

Wall Street Zen upgraded shares of BIO-key International (NASDAQ:BKYI) to a hold rating in a research report sent to investors on Saturday morning.

BIO-key International Price Performance

Shares of BIO-key International stock opened at $0.83 on Friday. BIO-key International has a fifty-two week low of $0.52 and a fifty-two week high of $3.68. The firm has a market capitalization of $4.82 million, a P/E ratio of -0.40 and a beta of 0.36. The company’s 50 day moving average price is $0.80 and its two-hundred day moving average price is $1.05.

BIO-key International (NASDAQ:BKYI) last issued its earnings results on Thursday, May 15th. The technology company reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.08. BIO-key International had a negative net margin of 74.11% and a negative return on equity of 181.57%. The firm had revenue of $1.61 million for the quarter, compared to analyst estimates of $1.30 million.

About BIO-key International

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.